(357 days)
Not Found
No
The device description focuses on the material properties and physical form of an absorbable implant, with no mention of software, algorithms, or data processing that would indicate AI/ML.
No.
The device is described as an absorbable, macroporous implant in sheet form used for fixation of non-load bearing bone defects. Its intended uses, such as for comminuted fractures and reconstructive procedures, indicate it is a structural support or repair device rather than a device that treats a disease or condition. While it aids in healing and recovery, its primary function is mechanical support.
No
The device is an implant used for fixation of bone defects in reconstructive procedures, not for identifying or investigating a disease, injury, or other condition.
No
The device description clearly states it is an absorbable, macroporous implant in sheet form made from polylactic acid (PLA), which is a physical material, not software. It also mentions the system includes resorbable screws and tacks.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information about a person's health. This information is used for diagnosis, monitoring, or screening.
- Device Description: The MacroPore Protective Sheet is an implantable device made of polylactic acid (PLA). It is used in the body to provide fixation for bone defects.
- Intended Use: The intended use clearly states it's for "trauma and reconstructive procedures in the midface and craniofacial skeleton." This involves surgical implantation and physical support of bone, not the analysis of bodily specimens.
The description and intended use of the MacroPore Protective Sheet align with a surgical implant or medical device used for structural support and repair within the body, not an IVD.
N/A
Intended Use / Indications for Use
MacroPore Protective Sheet (MPS) is intended for use in trauma and reconstructive procedures in the midface and craniofacial skeleton:
-
- Comminuted fractures of the naso-ethmoidal and infraorbital areas
-
- Comminuted fractures of the frontal sinus wall
-
- Trauma of the midface or craniofacial skeleton
-
- Reconstructive procedures of the midface or craniofacial skeleton.
The system is not intended for use in the mandible and/or for full load bearing procedures.
Product codes
87HRS, HWC
Device Description
MacroPore Protective Sheet is an absorbable, macroporous implant in sheet form manufactured from polylactic acid (PLA). The purpose of the sheet is to provide fixation of non-load bearing bone defects in the cranio-facial area of the mammalian skeletal system.
MPS can be cut with scissors, is thermoplastic when heated to 55 C (for example, by the use of sterile hot water) and thus can be conformed three dimensionally to any bone defect. It can be rolled into a tube or used as a flat sheet. It can be used in conjunction with internal bone fixation devices such as plates and screws which can be also used to fixate the MPS and prevent dislocation. The system includes a selection of resorbable screws and tacks.
MPS is provided in sheets of 40 x 40 mm and in premanufactured shapes and can be provided in other sizes as needed for particular surgical procedures. Its thickness ranges from 500 microns to 1000 microns according to the defect to be treated. The pore size ranges from 500 microns to 2000 microns with pores distributed uniformly throughout the sheet in an offset or aligned pattern.
MPS is fabricated from poly(L-lactide-co-D,L-lactide) 70:30.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Midface, craniofacial skeleton (specifically naso-ethmoidal and infraorbital areas, frontal sinus wall). Not intended for use in the mandible.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K960988, K955729, K922308, K900138
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.
(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
JUL 3 0 1998
MacroPore Protective Sheet (Protego™ System)
Image /page/0/Picture/3 description: The image shows a sequence of handwritten digits and a forward slash. The sequence starts with what appears to be the letter 'K', followed by the numbers '9', '7', '2', '9', then a forward slash '/', and finally the number '3'. The digits are written in a bold, dark font, making them stand out against the background.
June 2, 1998
ADMINISTRATIVE INFORMATION
| Manufacturer Name: | MacroPore, Inc.
3252 Holiday Court, Suite 223
La Jolla, CA 92037 |
|----------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------|
| Official Contact: | Christopher J. Calhoun
Telephone (619) 458-0900
Fax (619) 458-0994 |
| Representative/Consultant: | Floyd G. Larson
Pacific Materials and Interfaces
4329 Graydon Road
San Diego, CA 92130
Telephone (619) 792-1235
FAX (619) 792-1236 |
| DEVICE NAME | |
| Classification Name: | Plate, fixation, bone |
Trade/Proprietary Name: MacroPore Protective Sheet (Protego™ System)
Common Name:
Plating System
ESTABLISHMENT REGISTRATION NUMBER
MacroPore, Inc. has not yet obtained an Establishment Registration Number.
DEVICE CLASSIFICATION
In the Federal Register of July 2, 1982 [FR 47 page 29052], FDA proposed that bone fixation systems be classified as Class II, as shown in 21 CFR 888.3030. Although the listed Classification Name in 21 CFR is "single/multiple component metallic bone fixation appliances and accessories," the LactoSorb Trauma Plating System, a system manufactured from resorbable polymers and a predicate device for this submission, has been cleared under an expanded definition of that Classification Name. The LactoSorb device was reviewed by
1
the General and Plastic Surgery Device Section of the Surgical and Rehabilitation Devices Panel, and has been assigned Product Code 87HRS. We propose that MacroPore Protective Sheet (MPS), the subject of this Notification, be classified as shown above.
CONFORMANCE WITH PERFORMANCE STANDARDS
No performance standards have been established under Section 514. Voluntary standards with which the MacroPore Protective Sheet complies include American National Standards Institute (ANSI)/Association for the Advancement of Medical Instrumentation (AAMI)/ISO 11135-1994, Medical Devices - Validation and Routine Control of Ethylene Oxide Sterilization.
PACKAGING/LABELING/PRODUCT INFORMATION
MacroPore Protective Sheet will be packaged in an Ethylene Oxide (EtO) sterilizable package consisting of double heat sealed pouches, each pouch composed of a 48 gage polyester/0.002 LDPE top web and an uncoated 10739 Tyvek bottom web. Sterilization will be accomplished by ethylene oxide treatment for 6-6.5 hours at 7-9 psig in 10% EtO/90% HCFC. Sterilization will be validated using ANSVAAMI/ISO 11135-1994, Medical Devices -Validation and Routine Control of Ethylene Oxide Sterilization. The sterility assurance level (SAL) that MacroPore intends to meet for the MacroPore Protective Sheet is 104. The device is not represented to be "pyrogen free."
INTENDED USE
MacroPore Protective Sheet (MPS) is intended for use in trauma and reconstructive procedures in the midface and craniofacial skeleton:
-
- Comminuted fractures of the naso-ethmoidal and infraorbital areas
-
- Comminuted fractures of the frontal sinus wall
-
- Trauma of the midface or craniofacial skeleton
-
- Reconstructive procedures of the midface or craniofacial skeleton.
The system is not intended for use in the mandible and/or for full load bearing procedures.
DEVICE DESCRIPTION
Design Characteristics
MacroPore Protective Sheet is an absorbable, macroporous implant in sheet form manufactured from polylactic acid (PLA). The purpose of the sheet is to provide fixation of non-load bearing bone defects in the cranio-facial area of the mammalian skeletal system.
2
MPS can be cut with scissors, is thermoplastic when heated to 55 C (for example, by the use of sterile hot water) and thus can be conformed three dimensionally to any bone defect. It can be rolled into a tube or used as a flat sheet. It can be used in conjunction with internal bone fixation devices such as plates and screws which can be also used to fixate the MPS and prevent dislocation. The system includes a selection of resorbable screws and tacks.
MPS is provided in sheets of 40 x 40 mm and in premanufactured shapes and can be provided in other sizes as needed for particular surgical procedures. Its thickness ranges from 500 microns to 1000 microns according to the defect to be treated. The pore size ranges from 500 microns to 2000 microns with pores distributed uniformly throughout the sheet in an offset or aligned pattern.
Material Composition
MPS is fabricated from poly(L-lactide-co-D,L-lactide) 70:30.
EQUIVALENCE TO MARKETED PRODUCT
MacroPore Protective Sheet shares indications and design principles with the following predicate devices, each of which has been determined by FDA to be substantially equivalent to pre-amendment devices: LactoSorb Trauma Plating System from W. Lorenz, a unit of Biomet, Inc. (K960988, K955729), Tilghman Titanium Mesh Skeletal Orbit Liner from TiMesh, Inc. (K922308), Motech Titanium Mesh from Biedermann MOTECH GmbH (K900138), and Leibinger Titanium DynamicMesh.
Intended Use
The indications for use of MacroPore Protective Sheet (MPS) are not new indications in that they are the same as or are included in those for the predicate devices. MPS is intended for use in the craniofacial skeleton for fracture fixation in surgical reconstruction. Specific indications are:
for use in trauma and reconstructive procedures in the midface and craniofacial skeleton (comminuted fractures of the naso-ethmoidal and infraorbital areas. comminuted fractures of the frontal sinus wall, trauma of the midface or craniofacial skeleton, reconstructive procedures of the midface or craniofacial skeleton).
The system is not intended for use in the mandible and/or for full load bearing procedures.
The predicate devices share intended uses with MPS as follows: The LactoSorb Trauma Plating System and the titanium mesh products have identical intended uses with regard to fracture fixation to those of MPS with a thickness of 1000 microns.
3
Design and Materials
The design and functional characteristics of MacroPore Protective Sheet and the predicate devices are similar. The physical designs of MPS and the LactoSorb device both consist of a thin sheet with perforations. The LactoSorb Trauma Plating System is made from a copolymer of polylactic acid and polyglycolic acid and has low crystallinity. The composition and processing of LactoSorb devices are selected to permit 70% of its strength to be maintained in vivo for 6-8 weeks (sufficient time to facilitate fracture fixation), yet to degrade and be cleared from the body within 9 to 15 months. The poly(L-lactide-co-D,Llactide) 70:30 of which MPS is made has been shown in animal studies to degrade more slowly, and to be fully degraded after 36 months. Both Lacrosorb and MPS are essentially amorphous. It is believed that degradation of an amorphous matrix is less likely than that of a crystalline matrix to leave microscopic undegraded crystalline regions. Such material could cause osteolysis in the same way as does the polyethylene debris that results from wear of articulating surfaces.
4
510(k) Summary
SUMMARY: TABLE OF SUBSTANTIAL EQUIVALENCE
MacroPore Protective Sheet is substantially equivalent to the LactoSorl Liner, Motech Titanium Surgical Mesh and Titanium Dynamic Mesh ir
| Subject Device | ||
|---|---|---|
| MacroPore Protective Sheet | LactoSorb Trauma | |
| System | ||
| (K960988, K955) | ||
| INTENDED | ||
| USE | For use in trauma and | |
| reconstructive procedures in the | ||
| midface and craniofacial skeleton |
- Comminuted fractures of the
naso-ethmoidal and infraorbital
areas - Comminuted fractures of the
frontal sinus wall - Trauma of the midface or
craniofacial skeleton - Reconstructive procedures of the
midface or craniofacial skeleton | For use in trauma and
reconstructive proce
the midface and crani
skeleton - Comminuted frac
the naso-ethmoic
infraorbital areas - Comminuted frac
the frontal sinus - Trauma of the m
craniofacial skele - Reconstructive p
of the midface or
craniofacial skele |
| DESIGN | Sheet of 500 and 1000 microns
thickness, size 60 x 80 mm or as
required, with pores of 500 to 2000
microns diameter arranged in a
uniform offset or aligned pattern | Sheets of 500 and 1000
microns thickness, size
25 mm to 50 x 50 mm with
pores of 1500 to 2000
microns diameter arranaged in
a uniform aligned pattern |
| MATERIAL | poly(L-lactide-co-D,L-lactide)
70:30 (Resomer® LR 708),
amorphous | poly(L-lactide-co-glycolide)
82:18, low crystallinity |
5
1
ง Trauma Plating System, Tilghman Titanium Mesh Skeletal Orbit n the following respects:
| Predicate Devices | |||
|---|---|---|---|
| Plating | |||
| (729) | Tilghman Titanium | ||
| Mesh Skeletal Orbit | |||
| Liner (K922308) | Motech Titanium | ||
| Surgical Mesh | |||
| (K900138) | Titanium Dynamic | ||
| Mesh | |||
| F | |||
| Hures in | |||
| iofacial | |||
| tures of | |||
| al and | |||
| tures of | |||
| wall | |||
| dface or | |||
| iton | |||
| rocedures | |||
| ton | For use in orbital | ||
| bony defect repair/ | |||
| reconstruction | For use in reinforcing | ||
| weak bony tissues | |||
| such as in acetabular | |||
| cups, ... and | |||
| reconstruction of | |||
| oral-maxillo-cranio- | |||
| facial surgeries | For defect-bridging | ||
| reconstruction of | |||
| non-loadbearing bony | |||
| structures | |||
| 100 | |||
| zes 25 x | |||
| n, with | |||
| 0 | |||
| anged in | |||
| tern | Sheets formed to | ||
| various shapes | Sheets of 1000 | ||
| microns thickness, | |||
| formed to various | |||
| shapes | Sheets of 300 to 600 | ||
| microns thickness, | |||
| sizes of 40 x 40 mm | |||
| to 90 x 90 mm, with | |||
| open hole pattern, | |||
| including screw holes | |||
| of 1.0 mm to 2.3 mm | |||
| (colide) | |||
| ty | Titanium | Titanium | Titanium |
6
Image /page/6/Picture/2 description: The image shows the logo for the Department of Health & Human Services USA. The logo features a stylized eagle with three heads facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the eagle.
JUL 3 0 1998
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MacroPore, Inc. c/o Pacific Materials and Interfaces Mr. Floyd G. Larson 4329 Graydon Road San Diego, California 92130
Re: K972913 Trade Name: Macropore Protective Sheet (Protego System) Regulatory Class: II Product Code: HRS and HWC Dated: June 5, 1998 Received: June 8, 1998
Dear Mr. Larson:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that. through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
7
Page 2 - Mr. Floyd G. Larson
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
8
Device Name: MacroPore Protective Sheet
Indications for Use:
MacroPore Protective Sheet (MPS) is intended for use in trauma and reconstructive procedures in the midface and craniofacial skeleton:
-
- Comminuted fractures of the naso-ethmoidal and infraorbital areas
-
- Comminuted fractures of the frontal sinus wall
-
- Trauma of the midface or craniofacial skeleton
-
- Reconstructive procedures of the midface or craniofacial skeleton.
The system is not intended for use in the mandible and/or for full load bearing procedures.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY)
Prescription Use Over-Theounter Use
Concurrence of CDRH, Office of Device Evaluation (ODE)